Delivery Order SPE2DR25D9222-SPE2DR26FHLB0
Award Date 3/18/26
Potential Completion Date 4/8/26
Potential Value $3.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 13, 2026, for supply of Nuplazid 34 mg capsules, with a ceiling value of $11,771.46. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for NUPLAZID 34 mg capsule 30s with a ceiling value of $3,923.82. The order was issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 13, 2026, for $11,771.46 to supply Nuplazid 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables...
- The Defense Logistics Agency issued a $3,923.82 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, for Nuplazid 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the PPV-G GEN V, a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 12, 2026, for $11,771.46 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Nuplazid 34 mg capsules. DMS Pharmaceutical Group Inc. is a woman-owned small business. The parent contract, SPE2DR, is a single-award indefinite delivery contract with a $499.9 million ceiling and ultimate completion date of December 31, 2036, supporting pharmaceutical supply to...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $11,771.46 for supply of Nuplazid 34 mg capsule 30-count units, with ultimate completion by March 3, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the company's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) Indefinite Delivery Contract (SPE2DR), a single-award DLA pharmaceutical supply...
- The Defense Logistics Agency issued a $11,771.46 delivery order to DMS Pharmaceutical Group Inc. on February 4, 2026, for Nuplazid 34 mg capsule 30-count units under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical...
- The Defense Logistics Agency issued a $3,923.82 delivery order to DMS Pharmaceutical Group Inc. on March 16, 2026, for NUPLAZID 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order carries a firm fixed-price structure with an ultimate completion date of April 6, 2026. This delivery order is issued under the PPV-G GEN...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nuplazid (pimavanserin) 34 mg capsules in quantities of 30 units. This firm fixed-price delivery order, valued at $11,771.46, was awarded on January 20, 2026, with an ultimate completion date of February 10, 2026. The award carries no set-aside designation, indicating DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count). This firm fixed-price delivery order, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...